SCHEMBL23701221

SCHEMBL23701221

COCCn1cc(C(=O)OC)ccc1=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.58
KDM4E B2RXH2 3/20 0.56
GAA P10253 2/20 0.56
EPHX2 P34913 2/20 0.46
ALDH1A1 P00352 3/20 0.46
GLA P06280 1/20 0.46
PKM P14618 1/20 0.46
HPGD P15428 1/20 0.46
HTT P42858 1/20 0.46
KMT2A Q03164 1/20 0.46
HSD17B10 Q99714 1/20 0.46
MAPT P10636 4/20 0.45
BRD4 O60885 1/20 0.43
BRD2 P25440 1/20 0.43
BRD3 Q15059 1/20 0.43
BRDT Q58F21 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4257090 0.87 MAPT (0.47) LMNAKDM4EGAAEPHX2ALDH1A1
SCHEMBL21395223 0.86 LMNA (0.59) LMNAKDM4EGAAEPHX2ALDH1A1
SCHEMBL31139259 0.86 LMNA (0.59) LMNAKDM4EGAAALDH1A1PKM
SCHEMBL4248991 0.86 ALDH1A1 (0.51) LMNAKDM4EGAAEPHX2ALDH1A1
SCHEMBL9341114 0.84 LMNA (0.58) LMNAKDM4EGAAALDH1A1HSD17B10
SCHEMBL31139272 0.84 LMNA (0.58) LMNAKDM4EGAAALDH1A1MAPT
SCHEMBL4248316 0.84 EPHX2 (0.46) LMNAKDM4EGAAEPHX2ALDH1A1
SCHEMBL14007191 0.84 ALDH1A1 (0.49) LMNAKDM4EGAAEPHX2ALDH1A1
SCHEMBL8295098 0.83 LMNA (0.57) LMNAKDM4EGAAEPHX2ALDH1A1
SCHEMBL13701759 0.82 EPHX2 (0.46) LMNAKDM4EGAAEPHX2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4077306-B1 COMPOUNDS AND PROBES FOR IMAGING HUNTINGTIN PROTEIN CHDI FOUNDATION INC (US) 2025-05-07 EP disclosed
US-11992535-B2 Compounds and probes for imaging huntingtin protein CHDI FOUNDATION, INC. (US) 2024-05-28 US disclosed
US-20210236663-A1 COMPOUNDS AND PROBES FOR IMAGING HUNTINGTIN PROTEIN CHDI FOUNDATION, INC. 2021-08-05 US disclosed
US-20210236663-A1 COMPOUNDS AND PROBES FOR IMAGING HUNTINGTIN PROTEIN CHDI FOUNDATION, INC. 2021-08-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210236663-A1 COMPOUNDS AND PROBES FOR IMAGING HUNTINGTIN PROTEIN HTT, HYPK, HSPBP1 LMNA 857/4885KDM4E 4698/4885GAA 317/4885
US-11992535-B2 Compounds and probes for imaging huntingtin protein HTT, HYPK, HSPBP1 LMNA 857/4885KDM4E 4698/4885GAA 317/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.